Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

57.09
-4.2600-6.94%
Post-market: 57.090.00000.00%19:47 EDT
Volume:1.16M
Turnover:67.37M
Market Cap:1.67B
PE:-77.79
High:61.12
Open:61.12
Low:55.18
Close:61.35
52wk High:170.87
52wk Low:55.17
Shares:29.29M
Float Shares:19.94M
Volume Ratio:1.77
T/O Rate:5.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7339
EPS(LYR):-0.7339
ROE:-7.60%
ROA:-1.55%
PB:5.43
PE(LYR):-77.79

Loading ...

GeneDx Holdings Corp : Jefferies Cuts Target Price to $150 From $180

THOMSON REUTERS
·
Feb 24

GeneDx Holdings Corp : Btig Cuts Target Price to $170 From $200

THOMSON REUTERS
·
Feb 24

GeneDx Holdings Corp : Piper Sandler Cuts Target Price to $130 From $160

THOMSON REUTERS
·
Feb 24

GeneDx price target lowered to $150 from $180 at Jefferies

TIPRANKS
·
Feb 24

Stock Track | GeneDx Holdings Soars 5.15% Intraday After Q4 Earnings and Revenue Beat Estimates

Stock Track
·
Feb 24

BUZZ-U.S. STOCKS ON THE MOVE-Merck, Alphabet, JPMorgan Chase

Reuters
·
Feb 23

Shares of GeneDx Holdings up 3.5% Premarket After Q4 Results Beat

THOMSON REUTERS
·
Feb 23

GUIDANCE: (WGS) GeneDx Expects 2026 Revenue Range $540M to $555M, vs. FactSet Est of $538.8M

MT Newswires Live
·
Feb 23

GeneDx Q4 revenue rises to USD 121 million as exome and genome volume grows 34.3% to 27,761

Reuters
·
Feb 23

GeneDx Hldgs Q4 Adj. EPS $0.14 Beats $0.11 Estimate, Sales $120.989M Beat $120.407M Estimate

Benzinga
·
Feb 23

BRIEF-GeneDx Q4 Adjusted Net Income USD 4.4 Million

Reuters
·
Feb 23

GeneDx Holdings Corp: Reaffirms Guidance for Full Year 2026

THOMSON REUTERS
·
Feb 23

Earning Preview: GeneDx Holdings revenue is expected to increase by 46.43%, and institutional views are mostly bullish

Earnings Agent
·
Feb 16

BRIEF-Time Names Genedx CEO Katherine Stueland To The 2026 Time100 Health List Of The World’S Most Influential Leaders In Health

Reuters
·
Feb 11

Time Names GeneDx CEO Katherine Stueland to the 2026 Time100 Health List of the World’s Most Influential Leaders in Health

THOMSON REUTERS
·
Feb 11

Wells Fargo Upgrades GeneDx Holdings to Overweight From Equalweight

MT Newswires Live
·
Feb 09

GeneDx Holdings Corp. : Wells Fargo Raises to Overweight From Equal Weight

THOMSON REUTERS
·
Feb 09

U.S. RESEARCH ROUNDUP-Align Technology, Biogen, Citigroup

Reuters
·
Feb 09

GeneDx COO Bryan Dechairo Reports Disposal of Common Shares

Reuters
·
Feb 07

GeneDx Holdings Corp. to Release Fourth Quarter Financial Results

Reuters
·
Feb 03